Fourteen Cases of Appetite Loss Treated with Shoyogan

Abstract

Shoyogan is a Kampo prescription described in the Junqui Yaolue. Few cases have been reported using this medicine. This time, we prescribed shoyogan for 14 patients who suffered from severe appetite loss. We had positive outcomes as follows. We administered shoyogan to 8 patients with malignant disease. Six of them suffered from lung cancer. Shoyogan was effective in these patients. Shoyogan was not effective for the other 2 patients, with bile duct carcinoma and malignant lymphoma. The dietary intake was increased from 28 percent of meals supplied to 79 percent in the appetite-improved group. We also administered shoyogan to 6 patients with nonmalignant disease. It was effective for 3 patients : 1 with congestive heart failure and 2 with great trochanteric fractures of the femur. It was not effective for the other 3 patients, who suffered from anorexia, pneumonia and depression associated with diabetes mellitus. Shoyogan seems to be effective for patients with terminal lung cancer and maintains their quality of life. appetite, lung cancer, shoyogan, QOL

Shoyogan improves dietary intake in severely anorexic patients with malignant or non‐malignant disease

“…Nevertheless, approximately 2 h after oral shoyogan, her appetite improved; subsequently, her general condition strikingly improved and she survived for a further 2 months. Subsequently, we reported clinical efficacy in a study of 14 anorexic patients with malignant and nonmalignant disease [3]. In the present, larger-scale study, we have shown that shoyogan improves dietary intake of severely anorexic patients with a wide range of malignant and nonmalignant diseases.…”

“…We have shown that shoyogan improved dietary intake of a patient in the terminal stage of pulmonary cancer, leading to transient improvement of general condition [2]. We also reported that shoyogan improved the dietary intake of 14 severely anorexic patients with malignant or non-malignant disease [3].…”